Structure-based design of aliskiren, a novel orally effective renin inhibitor (Q28202603)

1

0 references

Jürgen Maibaum

2

0 references

Joseph Rahuel

3

0 references

Markus G Grütter

4

0 references

Nissim-Claude Cohen

5

0 references

Vittorio Rasetti

6

0 references

Heinrich Rüger

7

0 references

Richard Göschke

8

0 references

Stefan Stutz

9

0 references

Walter Fuhrer

10

0 references

Walter Schilling

11

0 references

Pascal Rigollier

12

0 references

Yasuchika Yamaguchi

13

0 references

Frederic Cumin

14

0 references

Hans-Peter Baum

15

0 references

Christian R Schnell

16

0 references

Peter Herold

17

0 references

Robert Mah

18

0 references

Chris Jensen

19

0 references

Eoin O'Brien

20

0 references

Martin P Bedigian

Biochemical and Biophysical Research Communications

22

0 references

language of work or name

English

0 references

publication date

5 September 2003

0 references

published in

0 references

volume

308

0 references

issue

4

0 references

page(s)

698-705

0 references

cites work

The cardiac renin-angiotensin-aldosterone system and hypertensive cardiac hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901451-7

Angiotensin II and renal fibrosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901451-7

Enalapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901451-7

Angiotensin II receptor antagonists role in arterial hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901451-7

The preparation, purification, and amino acid sequence of a polypeptide renin substrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901451-7

Is there a future for renin inhibitors?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901451-7

Functional and biochemical analysis of angiotensin II-forming pathways in the human heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901451-7

Pathways for angiotensin II generation in intact human tissue: evidence from comparative pharmacological interruption of the renin system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901451-7

Effects of a specific and long-acting renin inhibitor in the marmoset

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901451-7

Immediate blood pressure effects of the renin inhibitor enalkiren and the angiotensin-converting enzyme inhibitor enalaprilat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901451-7

Clinical Pharmacokinetics and Efficacy of Renin Inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901451-7

Structure-based drug design: the discovery of novel nonpeptide orally active inhibitors of human renin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901451-7

MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901451-7

Raster3D Version 2.0. A program for photorealistic molecular graphics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901451-7

Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901451-7

Synthesis and biological activity of some transition-state inhibitors of human renin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901451-7

No evidence for product inhibition of the renin-angiotensinogen reaction in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901451-7

The selectivity of statine-based inhibitors against various human aspartic proteinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901451-7

An easy radioimmunological microassay of renin activity, concentration and substrate in human and animal plasma and tissues based on angiotensin I trapping by antibody.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901451-7

Biochemical effects of prolonged renin inhibition in marmosets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901451-7

The crystal structures of recombinant glycosylated human renin alone and in complex with a transition state analog inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901451-7

Designing non-peptide peptidomimetics in the 21st century: inhibitors targeting conformational ensembles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901451-7

Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalapril

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901451-7

Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: a study of a United Kingdom population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901451-7

Continuation of initial antihypertensive medication after 1 year of therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901451-7

Clinical pharmacology of enalkiren, a novel, dipeptide renin inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901451-7

7 January 2021

inferred from DOI database lookup

Nonparallel effects of renin inhibitor treatment on plasma renin activity and angiotensins I and II in hypertensive subjects. An assay-related artifact

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901451-7

7 January 2021

inferred from DOI database lookup

Inhibition of renin secretion by angiotensin. II.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901451-7

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1016/S0006-291X(03)01451-7

1 reference

Consolidated OpenCitations Corpus – April 2017

release_jkn7rp4qivgffnhukhaewssvb4

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jkn7rp4qivgffnhukhaewssvb4

24 November 2022

mapped directly with Wikidata item

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

12927775

1 reference

Consolidated OpenCitations Corpus – April 2017